Lipocine Ownership 2024 | Who Owns Lipocine Now?


OverviewRevenueFinancialsChart

Institutional Ownership

11.32%

Insider Ownership

2.91%

Retail Ownership

85.77%

Institutional Holders

48.00

Lipocine Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO----3,000-100.00%-Jun 30, 2023
BANK OF AMERICA CORP /DE/----1,000-100.00%-Jun 30, 2023
WELLS FARGO & COMPANY/MN----612-100.00%-Jun 30, 2023
NORTHERN TRUST CORP----160,603-100.00%-Jun 30, 2023
PRICE T ROWE ASSOCIATES INC /MD/----174,600-100.00%-Jun 30, 2023
STATE STREET CORP----316,633-100.00%-Jun 30, 2023
VANGUARD GROUP INC----3,799,298-100.00%-Jun 30, 2023
MML INVESTORS SERVICES, LLC----77,000-100.00%-Jun 30, 2023
CALDWELL SUTTER CAPITAL, INC.----8,000-100.00%-Jun 30, 2023
AMERIPRISE FINANCIAL INC----44,000-100.00%-Jun 30, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----50,000-100.00%-Jun 30, 2023
MORGAN STANLEY----23,481-100.00%-Jun 30, 2023
ACADIAN ASSET MANAGEMENT LLC----12,010-100.00%-Jun 30, 2023
GROUP ONE TRADING, L.P.----2,046-100.00%-Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC----198,349-100.00%-Jun 30, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC----419,300-100.00%-Jun 30, 2023
TWO SIGMA INVESTMENTS, LP----253,977-100.00%-Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----830,063-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----184,538-100.00%-Jun 30, 2023
BLACKROCK INC.----1,467,420-100.00%-Jun 30, 2023

Lipocine's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO----3,000-100.00%-Jun 30, 2023
BANK OF AMERICA CORP /DE/----1,000-100.00%-Jun 30, 2023
WELLS FARGO & COMPANY/MN----612-100.00%-Jun 30, 2023
NORTHERN TRUST CORP----160,603-100.00%-Jun 30, 2023
PRICE T ROWE ASSOCIATES INC /MD/----174,600-100.00%-Jun 30, 2023
STATE STREET CORP----316,633-100.00%-Jun 30, 2023
VANGUARD GROUP INC----3,799,298-100.00%-Jun 30, 2023
MML INVESTORS SERVICES, LLC----77,000-100.00%-Jun 30, 2023
CALDWELL SUTTER CAPITAL, INC.----8,000-100.00%-Jun 30, 2023
AMERIPRISE FINANCIAL INC----44,000-100.00%-Jun 30, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----50,000-100.00%-Jun 30, 2023
MORGAN STANLEY----23,481-100.00%-Jun 30, 2023
ACADIAN ASSET MANAGEMENT LLC----12,010-100.00%-Jun 30, 2023
GROUP ONE TRADING, L.P.----2,046-100.00%-Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC----198,349-100.00%-Jun 30, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC----419,300-100.00%-Jun 30, 2023
TWO SIGMA INVESTMENTS, LP----253,977-100.00%-Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----830,063-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----184,538-100.00%-Jun 30, 2023
BLACKROCK INC.----1,467,420-100.00%-Jun 30, 2023

The largest Lipocine shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Lipocine (LPCN), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NEWSQUARE CAPITAL LLC----200-100.00%-Jun 30, 2023
WELLS FARGO & COMPANY/MN----612-100.00%-Jun 30, 2023
CITADEL ADVISORS LLC----900-100.00%-Jun 30, 2023
BANK OF AMERICA CORP /DE/----1,000-100.00%-Jun 30, 2023
ADVISOR GROUP HOLDINGS, INC.----1,150-100.00%-Jun 30, 2023
GROUP ONE TRADING, L.P.----2,046-100.00%-Jun 30, 2023
JPMORGAN CHASE & CO----3,000-100.00%-Jun 30, 2023
CALDWELL SUTTER CAPITAL, INC.----8,000-100.00%-Jun 30, 2023
CREATIVE PLANNING----10,000-100.00%-Jun 30, 2023
ACADIAN ASSET MANAGEMENT LLC----12,010-100.00%-Jun 30, 2023
SNOWDEN CAPITAL ADVISORS LLC----12,578-100.00%-Jun 30, 2023
CUTLER GROUP LLC / CA----13,000-100.00%-Jun 30, 2023
KESTRA PRIVATE WEALTH SERVICES, LLC----14,461-100.00%-Jun 30, 2023
CORNERSTONE WEALTH MANAGEMENT, LLC----16,000-100.00%-Jun 30, 2023
VIRTU FINANCIAL LLC----20,487-100.00%-Jun 30, 2023
MOLONEY SECURITIES ASSET MANAGEMENT, LLC----22,500-100.00%-Jun 30, 2023
MORGAN STANLEY----23,481-100.00%-Jun 30, 2023
UBS GROUP AG----25,113-100.00%-Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----26,772-100.00%-Jun 30, 2023
AARON WEALTH ADVISORS LLC----35,949-100.00%-Jun 30, 2023

As of Jun 30 2023, Lipocine's largest institutional buyer is NEWSQUARE CAPITAL LLC. The company purchased -0.20K stocks of LPCN, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC----3,799,298-100.00%-Jun 30, 2023
BLACKROCK INC.----1,467,420-100.00%-Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----830,063-100.00%-Jun 30, 2023
WEALTH EFFECTS LLC----756,674-100.00%-Jun 30, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC----419,300-100.00%-Jun 30, 2023
STATE STREET CORP----316,633-100.00%-Jun 30, 2023
KESTRA ADVISORY SERVICES, LLC----283,918-100.00%-Jun 30, 2023
TWO SIGMA INVESTMENTS, LP----253,977-100.00%-Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC----198,349-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----184,538-100.00%-Jun 30, 2023
PRICE T ROWE ASSOCIATES INC /MD/----174,600-100.00%-Jun 30, 2023
NORTHERN TRUST CORP----160,603-100.00%-Jun 30, 2023
TWO SIGMA ADVISERS, LP----132,000-100.00%-Jun 30, 2023
MML INVESTORS SERVICES, LLC----77,000-100.00%-Jun 30, 2023
EP WEALTH ADVISORS, LLC----66,983-100.00%-Jun 30, 2023
CHOREO, LLC----65,212-100.00%-Jun 30, 2023
WEALTHSPAN PARTNERS, LLC----65,200-100.00%-Jun 30, 2023
LPL FINANCIAL LLC----56,500-100.00%-Jun 30, 2023
BANK OF NEW YORK MELLON CORP----52,960-100.00%-Jun 30, 2023
CARSON ADVISORY INC.----52,000-100.00%-Jun 30, 2023

As of Jun 30 2023, Lipocine's biggest institutional seller is VANGUARD GROUP INC. The company sold -3.80M shares of LPCN, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC----3,799,298-100.00%-Jun 30, 2023
BLACKROCK INC.----1,467,420-100.00%-Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----830,063-100.00%-Jun 30, 2023
WEALTH EFFECTS LLC----756,674-100.00%-Jun 30, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC----419,300-100.00%-Jun 30, 2023
STATE STREET CORP----316,633-100.00%-Jun 30, 2023
KESTRA ADVISORY SERVICES, LLC----283,918-100.00%-Jun 30, 2023
TWO SIGMA INVESTMENTS, LP----253,977-100.00%-Jun 30, 2023
RENAISSANCE TECHNOLOGIES LLC----198,349-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----184,538-100.00%-Jun 30, 2023
PRICE T ROWE ASSOCIATES INC /MD/----174,600-100.00%-Jun 30, 2023
NORTHERN TRUST CORP----160,603-100.00%-Jun 30, 2023
TWO SIGMA ADVISERS, LP----132,000-100.00%-Jun 30, 2023
MML INVESTORS SERVICES, LLC----77,000-100.00%-Jun 30, 2023
EP WEALTH ADVISORS, LLC----66,983-100.00%-Jun 30, 2023
CHOREO, LLC----65,212-100.00%-Jun 30, 2023
WEALTHSPAN PARTNERS, LLC----65,200-100.00%-Jun 30, 2023
LPL FINANCIAL LLC----56,500-100.00%-Jun 30, 2023
BANK OF NEW YORK MELLON CORP----52,960-100.00%-Jun 30, 2023
CARSON ADVISORY INC.----52,000-100.00%-Jun 30, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----50,000-100.00%-Jun 30, 2023
AMERIPRISE FINANCIAL INC----44,000-100.00%-Jun 30, 2023
JANE STREET GROUP, LLC----40,868-100.00%-Jun 30, 2023
AARON WEALTH ADVISORS LLC----35,949-100.00%-Jun 30, 2023
TOWER RESEARCH CAPITAL LLC (TRC)----26,772-100.00%-Jun 30, 2023
UBS GROUP AG----25,113-100.00%-Jun 30, 2023
MORGAN STANLEY----23,481-100.00%-Jun 30, 2023
MOLONEY SECURITIES ASSET MANAGEMENT, LLC----22,500-100.00%-Jun 30, 2023
VIRTU FINANCIAL LLC----20,487-100.00%-Jun 30, 2023
CORNERSTONE WEALTH MANAGEMENT, LLC----16,000-100.00%-Jun 30, 2023
KESTRA PRIVATE WEALTH SERVICES, LLC----14,461-100.00%-Jun 30, 2023
CUTLER GROUP LLC / CA----13,000-100.00%-Jun 30, 2023
SNOWDEN CAPITAL ADVISORS LLC----12,578-100.00%-Jun 30, 2023
ACADIAN ASSET MANAGEMENT LLC----12,010-100.00%-Jun 30, 2023
CREATIVE PLANNING----10,000-100.00%-Jun 30, 2023
CALDWELL SUTTER CAPITAL, INC.----8,000-100.00%-Jun 30, 2023
JPMORGAN CHASE & CO----3,000-100.00%-Jun 30, 2023
GROUP ONE TRADING, L.P.----2,046-100.00%-Jun 30, 2023
ADVISOR GROUP HOLDINGS, INC.----1,150-100.00%-Jun 30, 2023
BANK OF AMERICA CORP /DE/----1,000-100.00%-Jun 30, 2023
CITADEL ADVISORS LLC----900-100.00%-Jun 30, 2023
WELLS FARGO & COMPANY/MN----612-100.00%-Jun 30, 2023
NEWSQUARE CAPITAL LLC----200-100.00%-Jun 30, 2023

Lipocine's largest sold out institutional shareholder by shares sold is VANGUARD GROUP INC, sold -3.80M shares, valued at -, as of undefined.

Lipocine Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
BRIDGEWAY FUNDS INC0.18%419,300--Mar 28, 2024
VANGUARD VALLEY FORGE FUNDS0.07%34,514--Mar 31, 2024
BRIDGEWAY FUNDS INC0.01%24,665--Mar 28, 2024
VANGUARD INDEX FUNDS0.01%3,661,092--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%90,600--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%776,908--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%74,945--Mar 31, 2024
Principal Exchange-Traded Funds0.00%17,539--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%50,000--Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%82,957--Jan 31, 2024
VANGUARD INDEX FUNDS0.00%215,359-74,283-25.65%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%45,037-205-0.45%Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%4,409--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%2,942--Jan 31, 2024
Blackstone Alternative Investment Funds0.00%3,700-100-2.63%Mar 31, 2023
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%2,659--Dec 31, 2023
iSHARES TRUST0.00%182,071--Mar 31, 2024
EQ ADVISORS TRUST0.00%13,124--Mar 31, 2024
Dimensional ETF Trust0.00%2,622--Jan 31, 2024
ADVANCED SERIES TRUST0.00%10,062--Mar 28, 2024
Blackstone Alternative Investment Funds0.00%318--Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%800--Mar 31, 2024
EQ ADVISORS TRUST0.00%386--Mar 31, 2024

Lipocine's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 419.30K shares, compromising 0.18% of its total assets.

Lipocine Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2348-11.11%
31 Dec, 225414.89%
30 Sep, 2247-4.08%
30 Jun, 22492.08%
31 Mar, 22489.09%
31 Dec, 21447.32%
30 Sep, 214113.89%
30 Jun, 2136-20.00%
31 Mar, 214521.62%
31 Dec, 203712.12%
30 Sep, 2033-
30 Jun, 203337.50%
31 Mar, 2024-7.69%
31 Dec, 1926-16.13%
30 Sep, 1931-6.06%
30 Jun, 19333.13%
31 Mar, 193223.08%
31 Dec, 1826-16.13%
30 Sep, 1831-
30 Jun, 18313.33%
31 Mar, 1830-31.82%
31 Dec, 17444.76%
30 Sep, 1742-14.29%
30 Jun, 1749-7.55%
31 Mar, 1753-11.67%
31 Dec, 166025.00%
30 Sep, 1648-23.81%
30 Jun, 166310.53%
31 Mar, 165716.33%
31 Dec, 154911.36%
30 Sep, 154418.92%
30 Jun, 1537105.56%
31 Mar, 1518-10.00%
31 Dec, 142033.33%
30 Sep, 14157.14%
30 Jun, 1414-

As of 31 Mar 23, 48 institutions are holding Lipocine's shares, representing a decrease of -11.11% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2310,021,220-4.82%
31 Dec, 2210,528,336-2.33%
30 Sep, 2210,780,011-9.45%
30 Jun, 2211,904,688-0.08%
31 Mar, 2211,914,59412.25%
31 Dec, 2110,614,62215.58%
30 Sep, 219,184,0180.65%
30 Jun, 219,124,85311.32%
31 Mar, 218,196,613-2.95%
31 Dec, 208,445,63618.30%
30 Sep, 207,139,26465.84%
30 Jun, 204,304,87818.23%
31 Mar, 203,640,966-30.39%
31 Dec, 195,230,54365.38%
30 Sep, 193,162,66310.84%
30 Jun, 192,853,246-0.60%
31 Mar, 192,870,35036.17%
31 Dec, 182,107,970-22.04%
30 Sep, 182,703,902-5.10%
30 Jun, 182,849,15836.13%
31 Mar, 182,092,907-44.72%
31 Dec, 173,785,692-19.01%
30 Sep, 174,674,248-14.32%
30 Jun, 175,455,442-26.35%
31 Mar, 177,407,304-10.00%
31 Dec, 168,230,135-0.06%
30 Sep, 168,234,820-4.47%
30 Jun, 168,620,324-8.08%
31 Mar, 169,378,5732.40%
31 Dec, 159,158,847-0.61%
30 Sep, 159,214,7159.77%
30 Jun, 158,394,41596.88%
31 Mar, 154,263,82421.68%
31 Dec, 143,504,103-8.55%
30 Sep, 143,831,5576.39%
30 Jun, 143,601,511-

Lipocine (LPCN) has 10.02M shares outstanding as of 31 Mar 23, down -4.82% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2311.32%8.00%
31 Dec, 2211.89%8.02%
30 Sep, 2212.18%6.73%
30 Jun, 2213.45%7.42%
31 Mar, 2213.46%3.70%
31 Dec, 2119.06%7.01%
30 Sep, 2116.49%6.14%
30 Jun, 2116.39%7.56%
31 Mar, 2114.72%6.40%
31 Dec, 2015.17%9.23%
30 Sep, 2012.82%21.45%
30 Jun, 207.73%18.08%
31 Mar, 206.54%7.41%
31 Dec, 199.39%29.12%
30 Sep, 195.68%21.63%
30 Jun, 195.12%19.28%
31 Mar, 195.15%35.97%
31 Dec, 183.79%16.06%
30 Sep, 184.86%18.55%
30 Jun, 185.12%36.22%
31 Mar, 183.76%8.13%
31 Dec, 176.80%9.65%
30 Sep, 178.39%8.75%
30 Jun, 179.80%5.54%
31 Mar, 1713.30%6.09%
31 Dec, 1614.78%6.76%
30 Sep, 1614.79%6.17%
30 Jun, 1615.48%5.46%
31 Mar, 1616.84%6.23%
31 Dec, 1516.45%6.01%
30 Sep, 1516.55%7.28%
30 Jun, 1515.07%25.71%
31 Mar, 157.66%19.34%
31 Dec, 146.29%13.29%
30 Sep, 146.88%16.45%
30 Jun, 146.47%-

As of 31 Mar 23, Lipocine is held by 11.32% institutional shareholders, representing a 8.00% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2315-
31 Dec, 221536.36%
30 Sep, 2211-42.11%
30 Jun, 2219-13.64%
31 Mar, 222237.50%
31 Dec, 2116-
30 Sep, 2116-11.11%
30 Jun, 2118-28.00%
31 Mar, 212525.00%
31 Dec, 20205.26%
30 Sep, 2019-9.52%
30 Jun, 2021110.00%
31 Mar, 2010-28.57%
31 Dec, 191440.00%
30 Sep, 1910-9.09%
30 Jun, 1911-26.67%
31 Mar, 1915150.00%
31 Dec, 186-40.00%
30 Sep, 1810-37.50%
30 Jun, 181645.45%
31 Mar, 1811-42.11%
31 Dec, 17195.56%
30 Sep, 1718-28.00%
30 Jun, 1725-3.85%
31 Mar, 1726-7.14%
31 Dec, 162847.37%
30 Sep, 1619-56.82%
30 Jun, 164462.96%
31 Mar, 1627-
31 Dec, 1527-10.00%
30 Sep, 1530-3.23%
30 Jun, 1531210.00%
31 Mar, 1510-23.08%
31 Dec, 14138.33%
30 Sep, 1412-14.29%
30 Jun, 1414-

15 institutional shareholders have increased their position in LPCN stock as of 31 Mar 23 compared to 15 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 23138.33%
31 Dec, 221220.00%
30 Sep, 2210-23.08%
30 Jun, 221344.44%
31 Mar, 229-35.71%
31 Dec, 211455.56%
30 Sep, 21950.00%
30 Jun, 216-33.33%
31 Mar, 219125.00%
31 Dec, 20433.33%
30 Sep, 203-
30 Jun, 203-40.00%
31 Mar, 20525.00%
31 Dec, 194-50.00%
30 Sep, 198-20.00%
30 Jun, 1910100.00%
31 Mar, 195-50.00%
31 Dec, 1810-9.09%
30 Sep, 181110.00%
30 Jun, 1810-
31 Mar, 1810-23.08%
31 Dec, 171330.00%
30 Sep, 1710-23.08%
30 Jun, 1713-7.14%
31 Mar, 1714-
31 Dec, 161416.67%
30 Sep, 16129.09%
30 Jun, 1611-35.29%
31 Mar, 161721.43%
31 Dec, 151440.00%
30 Sep, 1510233.33%
30 Jun, 15350.00%
31 Mar, 152100.00%
31 Dec, 141-50.00%
30 Sep, 142-
30 Jun, 14--

13 institutional shareholders have reduced their position in LPCN stock as of 31 Mar 23 compared to 12 in the previous quarter (a 8.33% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2348-11.11%10,021,220-4.82%11.32%8.00%15-138.33%
31 Dec, 225414.89%10,528,336-2.33%11.89%8.02%1536.36%1220.00%
30 Sep, 2247-4.08%10,780,011-9.45%12.18%6.73%11-42.11%10-23.08%
30 Jun, 22492.08%11,904,688-0.08%13.45%7.42%19-13.64%1344.44%
31 Mar, 22489.09%11,914,59412.25%13.46%3.70%2237.50%9-35.71%
31 Dec, 21447.32%10,614,62215.58%19.06%7.01%16-1455.56%
30 Sep, 214113.89%9,184,0180.65%16.49%6.14%16-11.11%950.00%
30 Jun, 2136-20.00%9,124,85311.32%16.39%7.56%18-28.00%6-33.33%
31 Mar, 214521.62%8,196,613-2.95%14.72%6.40%2525.00%9125.00%
31 Dec, 203712.12%8,445,63618.30%15.17%9.23%205.26%433.33%
30 Sep, 2033-7,139,26465.84%12.82%21.45%19-9.52%3-
30 Jun, 203337.50%4,304,87818.23%7.73%18.08%21110.00%3-40.00%
31 Mar, 2024-7.69%3,640,966-30.39%6.54%7.41%10-28.57%525.00%
31 Dec, 1926-16.13%5,230,54365.38%9.39%29.12%1440.00%4-50.00%
30 Sep, 1931-6.06%3,162,66310.84%5.68%21.63%10-9.09%8-20.00%
30 Jun, 19333.13%2,853,246-0.60%5.12%19.28%11-26.67%10100.00%
31 Mar, 193223.08%2,870,35036.17%5.15%35.97%15150.00%5-50.00%
31 Dec, 1826-16.13%2,107,970-22.04%3.79%16.06%6-40.00%10-9.09%
30 Sep, 1831-2,703,902-5.10%4.86%18.55%10-37.50%1110.00%
30 Jun, 18313.33%2,849,15836.13%5.12%36.22%1645.45%10-
31 Mar, 1830-31.82%2,092,907-44.72%3.76%8.13%11-42.11%10-23.08%
31 Dec, 17444.76%3,785,692-19.01%6.80%9.65%195.56%1330.00%
30 Sep, 1742-14.29%4,674,248-14.32%8.39%8.75%18-28.00%10-23.08%
30 Jun, 1749-7.55%5,455,442-26.35%9.80%5.54%25-3.85%13-7.14%
31 Mar, 1753-11.67%7,407,304-10.00%13.30%6.09%26-7.14%14-
31 Dec, 166025.00%8,230,135-0.06%14.78%6.76%2847.37%1416.67%
30 Sep, 1648-23.81%8,234,820-4.47%14.79%6.17%19-56.82%129.09%
30 Jun, 166310.53%8,620,324-8.08%15.48%5.46%4462.96%11-35.29%
31 Mar, 165716.33%9,378,5732.40%16.84%6.23%27-1721.43%
31 Dec, 154911.36%9,158,847-0.61%16.45%6.01%27-10.00%1440.00%
30 Sep, 154418.92%9,214,7159.77%16.55%7.28%30-3.23%10233.33%
30 Jun, 1537105.56%8,394,41596.88%15.07%25.71%31210.00%350.00%
31 Mar, 1518-10.00%4,263,82421.68%7.66%19.34%10-23.08%2100.00%
31 Dec, 142033.33%3,504,103-8.55%6.29%13.29%138.33%1-50.00%
30 Sep, 14157.14%3,831,5576.39%6.88%16.45%12-14.29%2-
30 Jun, 1414-3,601,511-6.47%-14---

Lipocine Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 25, 2023Patel Mahesh V.director, officer CEO and PresidentP-PurchaseBuy8,706$5.03$43.79K107,418
Mar 24, 2023Patel Mahesh V.director, officer CEO and PresidentP-PurchaseBuy150,000$0.32$48.00K1,678,090
Mar 20, 2023Ono Richard Danadirector-P-PurchaseBuy4,000$0.34$1.36K14,125
Mar 17, 2023Patel Mahesh V.director, officer CEO and PresidentP-PurchaseBuy50,000$0.33$16.50K1,528,090
Nov 28, 2022Papapetropoulos Spyrosdirector-P-PurchaseBuy21,739$0.47$10.22K21,739

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 25, 2023Patel Mahesh V.director, officer CEO and PresidentP-PurchaseBuy8,706$5.03$43.79K107,418
Mar 24, 2023Patel Mahesh V.director, officer CEO and PresidentP-PurchaseBuy150,000$0.32$48.00K1,678,090
Mar 20, 2023Ono Richard Danadirector-P-PurchaseBuy4,000$0.34$1.36K14,125
Mar 17, 2023Patel Mahesh V.director, officer CEO and PresidentP-PurchaseBuy50,000$0.33$16.50K1,528,090
Nov 28, 2022Papapetropoulos Spyrosdirector-P-PurchaseBuy21,739$0.47$10.22K21,739

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 07, 2024Papapetropoulos Spyrosdirector-A-AwardBuy1,764$7.05$12.44K5,410
Jun 07, 2024Ono Richard Danadirector-A-AwardBuy1,764$7.05$12.44K10,938
Jun 07, 2024Jene Jill M.director-A-AwardBuy1,764$7.05$12.44K5,410
Jun 07, 2024Higuchi John W.director-A-AwardBuy1,764$7.05$12.44K10,938
Jun 07, 2024Fink Jeffrey Arvindirector-A-AwardBuy1,764$7.05$12.44K10,938
Mar 12, 2024Patel Mahesh V.director, officer CEO and PresidentA-AwardBuy4,893--112,311
Mar 12, 2024Fogarty Kristaofficer Principal Accounting OfficerA-AwardBuy991--1,727
May 25, 2023Patel Mahesh V.director, officer CEO and PresidentP-PurchaseBuy8,706$5.03$43.79K107,418
May 12, 2023Papapetropoulos Spyrosdirector-A-AwardBuy30,000$0.27$7.97K62,000
May 12, 2023Higuchi John W.director-A-AwardBuy30,000$0.27$7.97K156,000
May 12, 2023Ono Richard Danadirector-A-AwardBuy30,000$0.27$7.97K166,000
May 12, 2023Jene Jill M.director-A-AwardBuy30,000$0.27$7.97K62,000
May 12, 2023Fink Jeffrey Arvindirector-A-AwardBuy30,000$0.27$7.97K166,000
Mar 24, 2023Patel Mahesh V.director, officer CEO and PresidentP-PurchaseBuy150,000$0.32$48.00K1,678,090
Mar 20, 2023Ono Richard Danadirector-P-PurchaseBuy4,000$0.34$1.36K14,125
Mar 17, 2023Patel Mahesh V.director, officer CEO and PresidentP-PurchaseBuy50,000$0.33$16.50K1,528,090
Jan 04, 2023Patel Mahesh V.officer Chief Executive OfficerA-AwardBuy300,000$0.41$123.00K2,542,395
Dec 22, 2022Patel Mahesh V.officer Chief Executive OfficerA-AwardBuy112,500$0.41$46.13K2,242,395
Dec 22, 2022Fogarty Kristaofficer Principal Accounting OfficerA-AwardBuy91,850$0.41$37.66K229,850
Nov 28, 2022Papapetropoulos Spyrosdirector-P-PurchaseBuy21,739$0.47$10.22K21,739

The last insider buy of LPCN was made by Patel Mahesh V. on May 25 2023, buying 8,706 shares at $5.03 per share (worth $43.79K).

Lipocine Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20245--
Q1 20242--
Q2 20236--
Q1 20234--
Q4 202251500.00%
Q3 20221--
Q2 20229--
Q1 20221--
Q4 202131300.00%
Q2 20213--
Q1 202111100.00%
Q4 20201811163.64%
Q2 20204--
Q1 20203--
Q4 2019136216.67%
Q2 20198--
Q4 20184--
Q2 20184--
Q4 2017101566.67%
Q2 20171--

5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Lipocine's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024---
Q2 20231--
Q1 20233--
Q4 20222--
Q3 20221--
Q2 20222--
Q1 2022---
Q4 20211--
Q2 2021---
Q1 2021---
Q4 2020-6-
Q2 2020---
Q1 20201--
Q4 201992450.00%
Q2 2019---
Q4 2018---
Q2 2018---
Q4 2017-6-
Q2 2017---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Lipocine's stocks.

Lipocine Peer Ownership


TickerCompany
ZVSAZyVersa Therapeutics, Inc.
CKPTCheckpoint Therapeutics, Inc.
RVPHReviva Pharmaceuticals Holdings, Inc.
VSTMVerastem, Inc.
RNAZTransCode Therapeutics, Inc.
ARDXArdelyx, Inc.
AVROAVROBIO, Inc.
SGTXSigilon Therapeutics, Inc.
KODKodiak Sciences Inc.
EYENEyenovia, Inc.
MBIOMustang Bio, Inc.
UNCYUnicycive Therapeutics, Inc.
CGTXCognition Therapeutics, Inc.
HEPAHepion Pharmaceuticals, Inc.
ZURAZura Bio Limited

LPCN Ownership FAQ


Lipocine is owned by institutional shareholders (11.32%), insiders (2.91%), and public (85.77%). The largest institutional shareholder of Lipocine is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.18% of total shares).

Lipocine's major institutional shareholders are JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, and PRICE T ROWE ASSOCIATES INC /MD/. The top five shareholders own together 0% of the company's share outstanding.

As of Mar 2023, there are 48 institutional shareholders of Lipocine.

JPMORGAN CHASE & CO owns 0 shares of Lipocine, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).

As of Jun 2023, BANK OF AMERICA CORP /DE/ holds 0 shares of Lipocine (LPCN), compromising 0% of the company, valued at $0.

WELLS FARGO & COMPANY/MN is the third largest holder of Lipocine. The company owns 0 of the company's shares outstanding (worth $0).